The U.S. Speech Therapy market has been witnessing significant growth in the recent years. Speech therapy, also known as speech-language pathology, refers to the evaluation and treatment of speech and language problems, including issues with sounds, fluency, voice and communication skills. Some of the common conditions treated through speech therapy include stuttering, voice disorders, apraxia and aphasia. Rising prevalence of neurological disorders, increasing pediatric population, and growing awareness about effective speech therapy services are some of the key factors fueling the demand for speech therapy in the U.S. According to market estimates, the U.S. speech therapy industry is projected to exhibit a CAGR of over 8.0% during the forecast period and reach a valuation of USD 9.08 Bn by 2032.
Market Dynamics:
Growing geriatric population susceptible to conditions such as Parkinson's disease and strokes is a major driver for the U.S. speech therapy market. Moreover, increasing prevalence of autism spectrum disorder among children has significantly upped the requirement for early diagnosis and treatment via speech therapy. On the other hand, high costs associated with therapy sessions and shortage of skilled professionals are some of the key challenges restraining the market growth. However, adoption of telehealth and virtual sessions during pandemic has provided new opportunities for market expansion. Integration of advanced technologies such as smartphones, tablets and VR aids is also expected to open up new avenues over the coming years.
Key Features of the Study:
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on U.S. Speech Therapy Market” - forecast to 2032
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients